RGA5 is a component of the Pia resistance-protein pair (RGA4/RGA5) from Oryza sativa L. japonica. It acts as an immune receptor that directly recognizes the effector AVR1-CO39 from Magnaporthe oryzae via a C-terminal non-LRR domain (RGA5A_S). The interaction between RGA5A_S and AVR1-CO39 relieves the repression of RGA4, leading to effector-independent cell death. To determine the structure of the complex of RGA5A_S and AVR1-CO39 and to understand the details of this interaction, the complex was prepared by fusing the proteins together, by mixing them in vitro or by co-expressing them in one host cell. Samples purified via the first two strategies were crystallized under two different conditions. A mixture of AVR1-CO39 and RGA5A_S (complex I) crystallized in 1.1 M ammonium tartrate dibasic, 0.1 M sodium acetate-HCl pH 4.6, while crystals of the fusion complex RGA5A_S-TEV-AVR1-CO39 (complex II) were grown in 2 M NaCl. The crystal of complex I belonged to space group P3 1 21, with unit-cell parameters a = b = 66.2, c = 108.8 Å , = = 90, = 120 . The crystals diffracted to a Bragg spacing of 2.4 Å , and one molecule each of RGA5A_S and AVR1-CO39 were present in the asymmetric unit of the initial model. The crystal of complex II belonged to space group I4, with unit-cell parameters a = b = 137.4, c = 66.2 Å , = = = 90
Crystallization of the rice immune receptor RGA5A_S with the rice blast fungus effector AVR1-CO39 prepared via mixture and tandem strategies 
Introduction
Rice is an important staple food for more than 50% of the population of the world. However, the rice plant is constantly affected by biotic (Robert-Seilaniantz et al., 2011) and abiotic (Hua, 2013) stresses from the seedling to the adult stages. Rice blast (Ribot et al., 2008) , which is caused by the ascomycete fungal pathogen Magnaporthe oryzae, is the most devastating disease of rice and represents a major threat to food security. Specific interactions between the avirulence (Avr) genes in M. oryzae and the matching resistance (R) genes in rice induce strong defences associated with a hypersensitive response (HR; Dodds & Rathjen, 2010) . To date, more than 100 major rice-blast R genes have been genetically characterized (Sharma et al., 2012) . Among 25 cloned R genes, 23 encoded cytoplasmic nucleotide-binding Liu et al., 2014) . Only 11 corresponding Avr genes from M. oryzae have been cloned (Pieterse et al., 2014; Devanna et al., 2014; Wu et al., 2015; Yoshida et al., 2009) . In several cases, rice-blast resistance has been shown to be conferred not by individual NLR proteins but by functional pairs of NLR proteins. The two NLR proteins in each pair cooperate to exert the pathogen-recognition and signalling functions (Zhai et al., 2014; Kanzaki et al., 2012; Cesari et al., 2013) .
RGA4 and RGA5 form a well studied NLR pair encoded by the Pia resistance gene in rice (Cesari et al., 2013) . RGA4 acts as a constitutive cell-death inducer, while RGA5 acts as an effector-binding receptor and a repressor of RGA4 signalling activity. RGA5 forms a heterocomplex with RGA4 to prevent cell death mediated by RGA4 in the absence of the effector AVR1-CO39. The effector physically interacts with an effector-binding domain of RGA5 (RGA5A_S, including a heavy-metal-associated domain; HMA) to relieve this suppression, resulting in a resistance response and HR (Cé sari et al., 2013 (Cé sari et al., , 2014 . However, the precise function of the HMA domain in direct molecular recognition of the effector is still unclear in plant NLR biology. Little is known about how plant-pathogen effectors are directly recognized by NLRs at the molecular level. Another NLR pair in rice (Pik-1/Pik-2) recognizes the AVR1-PikD effector of M. oryzae via an HMA domain (Pikp-HMA). The crystal structure of the Pikp-HMA-AVR-PikD complex has been resolved, and the structure revealed the details of the protein-protein molecular interactions involved in effector recognition (Maqbool et al., 2015) . It remains unknown whether the interaction between RGA5A_S and AVR1-CO39 takes place according to the same model as that involving Pikp-HMA and AVR-PikD.
In this study, the binding affinity of AVR1-CO39 for RGA5A_S was determined using isothermal titration calorimetry (ITC) in order to further verify the formation of RGA5A_S-AVR1-CO39 complexes prior to crystallization. The complexes were prepared using two different methods and the purified samples were crystallized under two different conditions. We believe that further structural characterization of the interaction between RGA5A_S and AVR1-CO39 will lead to a better understanding of the mechanism underlying effector recognition by NLR proteins.
Materials and methods

Generation of expression constructs
The nucleotide sequences encoding RGA5A_S (residues Leu982-Met1116) and AVR1-CO39 (residues Ala22-Cys89, lacking the signal peptide) were codon-optimized for expression in Escherichia coli and then chemically synthesized. Polymerase chain reaction products were generated using sticky-end cloning (Pham et al., 1998) using the primers shown in Table 1 and were then inserted into the pETM-13 and pET28a expression vectors (kindly supplied by Dr Arie Geerlof, EMBO, Heidelberg, Germany) using the NcoI and XhoI restriction sites. The constructs supported the expression of an RGA5A_S protein without a fusion tag and an AVR1-CO39 protein with a C-terminal 6ÂHis tag. The homologous recombination method (Raymond et al., 1999) was used to subclone both RGA5A_S and AVR1-CO39 into the pET-GB1 expression vector (kindly supplied by Dr Arie Geerlof, EMBO, Heidelberg, Germany) to generate a tandem fusion protein with an N-terminal 6ÂHis tag and a cleavage site (6ÂHis-RGA5A_S-TEV-AVR1-CO39). The TEV cleavage site was incorporated to produce a fusion protein with a longer flexible linker to facilitate cleavage to obtain the two components. All constructs were verified by DNA sequencing.
Protein expression and purification
All recombinant proteins were overexpressed in E. coli BL21 (DE3) cells. The cells were grown in lysogeny broth in a shaking incubator at 310 K. When the optical density at 600 nm (OD 600 ) reached 0.6-0.8, protein expression was induced with 0.1 mM isopropyl -d-1-thiogalactopyranoside and the cells were further incubated at 291 K for 18-20 h. The cells were collected by centrifugation at 6000 rev min À1 for 10 min at 277 K and were then resuspended in 60-80 ml lysis buffer (20 mM Tris-HCl pH 8, 500 mM NaCl). The cell pellets were disrupted by ultrasonication and the debris was removed by centrifugation at 12 000 rev min À1 for 30 min at 277 K. The lysates were first purified using a nickel-chelating Sepharose Fast Flow agarose column. The bound proteins were stepeluted with elution buffer (lysis buffer containing 500 mM imidazole). The eluted fractions were concentrated and further purified by chromatography using Superdex 75 10/300 GL gel-filtration columns (GE Healthcare, Little Chalfont, England) that had been equilibrated in gel-filtration buffer [20 mM Tris-HCl pH 8, 150 mM NaCl, 5 mM dithiothreitol (DTT), 4 mM ethylenediaminetetraacetic acid (EDTA)]. The peak fractions were pooled and concentrated to 4-12 mg ml À1 . All experimental steps were performed at 277 K.
Analytical ultracentrifugation
Sedimentation-velocity analytical ultracentrifugation (SV-AUC) was carried out in a Beckman Coulter XL-I analytical ultracentrifuge to determine complex formation by the fusion protein RGA5A_S-TEV-AVR1-CO39. The fusion complex was dissolved at 1 mg ml À1 in 20 mM Tris-HCl pH 8.0, 150 mM NaCl. The complex was centrifuged using an An-50Ti rotor at a speed of 40 000 rev min À1 and a rotor temperature of 20 C. Data were collected using interference optics and the related sedimentation-coefficient distribution c(s) was calculated using the SEDFIT software (Brown & Schuck, 2006) . 
ITC
ITC experiments were performed at 298 K using a MicroCal iTC 200 instrument (Malvern Instruments, Malvern, England). The purified proteins were dissolved in 20 mM Tris-HCl pH 8, 150 mM NaCl. 20 injections of AVR1-CO39 (420 mM) in the injection syringe were titrated by adding 2 ml at a time to a 300 ml sample cell containing 40 mM RGA5A_S. The stirring rate was 750 rev min À1 and the dynamics of the thermal power were recorded every 5 s. The heat-exchange data for all of the injections were fitted to a single-site binding model using the Origin software suite (OriginLab, Northampton, Massachusetts, USA).
Crystallization
RGA5A_S and AVR1-CO39-6ÂHis were mixed in a 1:1 molar ratio and the mixture was incubated on ice overnight prior to cocrystallization. The initial crystallization screening was based on the crystallization conditions for RGA5A_S (Huang et al., 2015) . The proteins were dissolved in 20 mM NaH 2 PO 4 /Na 2 HPO 4 pH 7, 500 mM NaCl, 1 mM DTT. Initial crystallization was based on the sitting-drop vapour-diffusion method using an Oryx4 crystallization robot (Douglas Instruments, Hungerford, England) with 0.2 M ammonium citrate, 25%(w/v) PEG 3350. Drops (0.5 ml) were prepared by diluting the protein complex solution to various concentrations using the reservoir solution and then equilibrating the drops against 35 ml well solution. The compositions of the solutions are shown in Table 2 . However, no crystals grew. The crystallization conditions for the two complexes were further screened using the MCSG-1, MCSG-2, MCSG-3 and MCSG-4 screens from Microlytic (http://www.microlytic.com) using a random-screening strategy. The final crystallization conditions for both complexes are shown in Table 2 .
Data collection and structure determination
The crystals were first transferred into reservoir solution supplemented with an additional 20%(w/v) glycerol as a cryoprotectant and were then flash-cooled by plunging them into liquid nitrogen. Diffraction data were collected at 100 K on beamline BL18U at the Shanghai Synchrotron Research Facility (SSRF). The data were indexed and scaled with xia2 as implemented in the CCP4 suite (Winn et al., 2011; Winter, 2010) 
Figure 2
Isothermal titration calorimetry (ITC) measurements of the interaction between AVR1-CO39 and RGA5A_S. The upper panel shows raw data for AVR1-CO39 titrated with RGA5A_S. The area of each injection peak corresponds to the total heat release for that injection. The bottom panel shows the integrated heat release for all injections (squares) and the best fit (solid line) to a single-site binding model using the Origin software suite.
models. The data-collection and processing statistics for both structures are listed in Table 3 .
Results and discussion
Three strategies are commonly used to prepare protein complexes for crystallization. In the first strategy, each individual protein in the complex is purified separately and the purified proteins are mixed to form the complex prior to crystallization (mixing strategy). In the second approach, plasmids that express protein A with a fusion tag and protein B without a tag are cotransformed into a microbial strain for protein expression; these are then purified together to form the complex (known as the coexpression strategy; Ke et al., 2015; Maqbool et al., 2015) . A third, linker-based strategy fuses the two proteins together to prepare tandem complex proteins (Lucato et al., 2015; Morita et al., 2017) . The second and third strategies are often used to prepare specific proteins with properties such as poor stability, low expression levels or weak binding affinity. We failed to obtain soluble proteins using the co-expression strategy (data not shown); however, RGA5A_S, AVR1-CO39 and the fusion complex RGA5A_S-TEV-AVR1-CO39 were efficiently expressed in E. coli BL21 (DE3) cells. Using similar purification processes, the three proteins were first purified using nickel-chelating Sepharose Fast Flow agarose, followed by gel filtration using a Superdex 75 10/300 GL column. AVR1-CO39 was in a homogeneous state. In contrast, RGA5A_S showed a wide elution range from the gel-filtration column. For the fusion complex, the elution volume of 10.6 ml from this column corresponded to a molecular weight of 37.7 kDa, which was close to the expected molecular weight for the tandem complex (26.5 kDa; Fig. 1a ). SV-AUC was carried out in a Beckman Coulter XL-I analytical ultracentrifuge to determine the molecular weight of the RGA5A_S-TEV-AVR1-CO39 fusion complex. The SV-AUC data showed that the major component had a sedimentation coefficient of 2.413 S ($23.7 kDa), corresponding to a monomer of the complex (26.5 kDa; Fig. 1b) . These results indicate that the fusion complex formed a monomer in solution.
The binding affinity between RGA5A_S and AVR1-CO39 was determined by isothermal titration calorimetry (Fig. 2) to further verify the formation of an RGA5A_S-AVR1-CO39 complex prior to cocrystallization. In agreement with previously reported yeast two-hybrid results (Cé sari et al., 2013 (Cé sari et al., , 2014 , the ITC data showed that there is specific, direct binding with a one-site model and an equilibrium dissociation constant (K d ) of 5.4 mM for RGA5A_S and AVR1-CO39.
The RGA5A_S-AVR1-CO39 complex (complex I) was prepared by mixing the proteins together in a 1:1 molar ratio and was successfully crystallized after two or three weeks in 0.1 M sodium acetate-HCl pH 4.6, 1.1 M ammonium tartrate dibasic (Fig. 3a) . Additionally, the TEV cleavage site in the fusion complex was not cleaved after purification and crystals of the fusion complex were grown in reservoir solution consisting of 2 M NaCl after 70 d (Fig. 3b ). The two crystals had different forms and diffracted to Bragg spacings of 2.4 and 2.72 Å resolution.
The initial models were constructed by the molecularreplacement method using Phaser (McCoy et al., 2007) . For complex I, the crystal belonged to space group P3 1 21, with unit-cell parameters a = 66.2, b = 66.2, c = 108.8 Å . The calculated Matthews coefficient indicated that there was one molecule of RGA5A_S and one molecule of AVR1-CO39 in the asymmetric unit, with an approximate solvent content of 64.2%. Using Phaser (McCoy et al., 2007) , a solution with a rotation-function Z-score of 6.3, a translation-function Zscore of 33.2 and a convincing log-likelihood gain of 1021 was identified. Subsequently, the initial structure was refined using PHENIX (Adams et al., 2010) , which resulted in a model with an R work of 34.6% and an R free of 36.9%. The crystal of the fusion complex belonged to space group I4, with unit-cell parameters a = 137.4, b = 137.4, c = 66.2 Å . There were two molecules of RGA5A_S and two molecules of AVR1-CO39 in the asymmetric unit, with a solvent content of 68.5%. The molecular-replacement solution had rotation-function and translation-function Z-scores of 3.4 and 15, respectively, and a log-likelihood gain of 1729. Initial refinement of the structure resulted in a model with an R work of 28.5% and an R free of 30.6%.
Structure refinement is currently ongoing. A detailed structural analysis of the interaction between RGA5A_S and AVR1-CO39 should help us to determine the molecular mechanism by which the pathogen is directly recognized by the host. The result also shows that different strategies should be employed to prepare complexes to increase the success rate of crystallization.
